BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 22322379)

  • 1. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
    Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
    Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
    Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
    Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
    Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
    Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia.
    Zhu H; Wang D; Zhang L; Xie X; Wu Y; Liu Y; Shao G; Su Z
    Oncol Rep; 2014 Sep; 32(3):935-42. PubMed ID: 24994549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of the function of nuclear factor-κB-dependent epithelial to mesenchymal transition in pancreatic cancer cells under hypoxic conditions].
    Cheng ZX; Sun B; Wang SJ; Zhou HX; Jia G; Kong R; Wang G; Jiang HC
    Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):446-51. PubMed ID: 22883954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study.
    Na DC; Lee JE; Yoo JE; Oh BK; Choi GH; Park YN
    Exp Mol Pathol; 2011 Feb; 90(1):66-73. PubMed ID: 20969862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
    Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
    Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma.
    Skoda J; Hermanova M; Loja T; Nemec P; Neradil J; Karasek P; Veselska R
    PLoS One; 2016; 11(7):e0159255. PubMed ID: 27414409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
    Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y
    Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
    Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
    Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD133 promotes the invasion and metastasis of gastric cancer via epithelial-mesenchymal transition].
    Cai C; Yu JW; Wu JG; Lu RQ; Ni XC; Wang SL; Jiang BJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):662-7. PubMed ID: 23888452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis.
    Ding Q; Miyazaki Y; Tsukasa K; Matsubara S; Yoshimitsu M; Takao S
    Mol Cancer; 2014 Jan; 13():15. PubMed ID: 24468059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of RNA interference inhibition to expression of CD133 on tumor cell biological characteristics in KATO-III CD133(+) cells of human gastric cancer].
    Wang SL; Yu JW; Cai C; Lu RQ; Wu JG; Ni XC; Jiang BJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):889-94. PubMed ID: 24062002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cells.
    Tsukasa K; Ding Q; Yoshimitsu M; Miyazaki Y; Matsubara S; Takao S
    Hum Cell; 2015 Oct; 28(4):167-74. PubMed ID: 25997702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.
    Du Z; Qin R; Wei C; Wang M; Shi C; Tian R; Peng C
    Dig Dis Sci; 2011 Mar; 56(3):741-50. PubMed ID: 20683663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.